| Patient Education |
|
Click here for patient education.
|
|
You are in: eMedicine Specialties >
Dermatology > BACTERIAL INFECTIONS
Yaws
Article Last Updated: Mar 23, 2007
AUTHOR AND EDITOR INFORMATION
Section 1 of 9
Author: Caroline L Levine, MD, Staff Physician, Dermatology, Emerson Hospital, Mt. Aburn Hospital, MIT
Caroline L Levine is a member of the following medical societies: American Academy of Dermatology
Editors: Donald Belsito, MD, Clinical Professor, Department of Internal Medicine, Division of Dermatology, University of Missouri at Kansas City; Private Practice, American Dermatology Associates, LLC; Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA; Paul Krusinski, MD, Director of Dermatology, Professor, Department of Internal Medicine, Fletcher Allen Health Care, University of Vermont; Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System
Author and Editor Disclosure
Synonyms and related keywords:
pian, frambesia, boubas, parangi, paru, Treponema pallidum subsp pertenue, T pallidum subsp pertenue, frambesia tropica
Background
Yaws is the most prevalent infectious, nonvenereal, treponemal disease and is caused by Treponema pallidum subsp pertenue. The disease is transmitted by direct skin contact and usually affects children, with a peak incidence in those aged 6-10 years. Similar to syphilis, yaws can persist for years as a chronic, relapsing disease.
Yaws continues to be endemic along the tropical belt in areas characterized by hot temperatures, high humidity, and heavy rainfall. These conditions coupled with the persistence of poverty, poor sanitation, overcrowding, and lack of public health surveillance allow for disease perpetuation.
Pathophysiology
Cutaneous lesions characterize the primary and secondary stages. The tertiary stage may include involvement of skin, bones, and joints.
Frequency
International
In the early 1950s, the estimated number of active cases in areas of Africa, Asia, South America, Central America, and the Pacific Islands was 25-150 million. After the World Health Organization (WHO) supported mass treatment campaigns from 1954-1963, researchers observed a dramatic fall in the prevalence. Since then, however, cases of yaws rebounded because of the lack of public health surveillance and inadequate treatment facilities. Currently, researchers estimate that 100 million children are at risk of acquiring yaws.
Mortality/Morbidity
Unless treated, yaws can become a chronic, relapsing disease with skin, bone, and joint involvement. In 10% of cases, patients enter a late stage (tertiary stage) characterized by destructive cutaneous lesions and severely deforming bone and joint lesions. Neurologic and ophthalmologic involvement may also occur.
Sex
No sexual predilection exists.
Age
Children serve as the primary reservoir for yaws. It is most common in children younger than 15 years, with the peak incidence occurring between ages 6 and 10 years.
History
The typical patient is young and from an endemic area and has been exposed to infected persons with active disease.
Physical
Yaws has 3 clinical stages: primary, secondary, and tertiary. Stages are interspersed with asymptomatic latent periods.
- Primary stage
- After an incubation period of 9-90 days (with an average of 3 wks), the primary lesion, or the mother yaw, develops at the site of inoculation after a scratch, a bite, or an abrasion of exposed skin, most commonly on the legs, the feet, or the buttocks.
- The lesion is a reddish, nontender, and, occasionally, pruritic papulonodule.
- The mother yaw ulcer develops a honey-brown crust and enlarges horizontally to 1-5 cm in diameter, sometimes coalescing with satellite lesions. The crust frequently sloughs off and reveals a raspberrylike base (hence the synonym frambesia).
- On rare occasions, a primary lesion is not seen.
- Because the exudate of the raspberrylike ulcer is teeming with treponemes, these lesions are considered highly infectious.
- Lymphadenopathy, fever, and joint pain may accompany this stage.
- The mother yaw resolves spontaneously in 2-9 months, leaving an atrophic scar with central hypopigmentation and peripheral hyperpigmentation.
- Secondary stage
- Following a period of latency (about 6-16 wk after the primary stage), an eruption of disseminated skin lesions, bone lesions, and constitutional symptoms appears.
- The cutaneous lesions, or the daughter yaws, resemble the mother yaw but are smaller (up to 2 cm in diameter) and are frequently located adjacent to body orifices, particularly the mouth and the nose.
- The daughter yaws expand, ulcerate, and exude a fibrinous fluid teeming with treponemes, which dries into a crust. The exudate attracts flies, which are bothersome to the person who is affected.
- Occasionally, central resolution yields circinate or annular scaly lesions resembling fungal infections. These lesions are referred to as tinea yaws.
- Papulosquamous patches and plaques that resemble syphilis may be noted on any part of the body.
- Lesions in the axillae or the groin resemble condylomata lata; lesions on the mucous membranes resemble hypertrophic mucous patches.
- Piannic onychia is a paronychia caused by papillomas in the nail fold.
- Papillomas on the plantar surfaces can form thick, hyperkeratotic plaques that may become fissured or eroded. Lesions are painful and cause a deliberate crablike gait (crab yaws). Macular and hyperkeratotic lesions on the palms and the soles resembling syphilis may also be present.
- Skeletal involvement includes painful osteoperiostitis and fusiform soft tissue swelling of the metatarsals and the metacarpals. Some of the early bone changes can be seen on radiographs. Periosteal thickening can often be palpable.
- Secondary-stage manifestations are generally nonscarring and reversible, subsiding in weeks to months.
- Patients may develop relapses at intervals up to 5 years after infection. Relapsing lesions tend to occur in the perioral, perianal, and periaxillary areas. The disease then enters a noninfectious latent period, and patients do not exhibit any signs or symptoms.
- Tertiary stage
- In about 10% of cases, after 5-15 years of latency, a late stage develops, characterized by destructive skin lesions, bone lesions, and possible neurologic and ophthalmologic involvement.
- Progressively enlarging, painless, subcutaneous nodules develop, which undergo abscess formation, necrosis, and ulceration. Lesions have well-defined edges and an indurated base with granulation tissue and yellowish slough.
- Ulcers may become infected, causing destruction of underlying structures. They may also coalesce, forming serpiginous tracts that heal with keloid formation, which leads to crippling deformities and contractures.
- Hyperkeratosis and keratoderma of the palms and the soles as well as juxta-articular ulcerated gummatous nodules may accompany lesions.
- Late skeletal lesions consist of hypertrophic periostitis, gummatous periostitis, osteitis, and osteomyelitis. Chronic osteitis of the tibia can lead to saber shins. In about 1% of patients, bilateral hypertrophic osteitis of the external aspects of the nasal processes of the maxillae with persistent swelling occurs. This condition is referred to as goundou, which slowly progresses over 5-20 years and eventually may lead to massive destruction and perforation of the nose and the palate (gangosa).
- Neurologic and ophthalmologic involvement is debated in the literature. Some reports suggest that disc atrophy, optic atrophy, and myeloneuropathies may occur.
- Attenuated yaws
- Some reports describe an attenuated, less contagious form of yaws in areas of low disease prevalence.
- A solitary patch or a few, dry, flat, gray patches confined to the skin folds characterize attenuated yaws.
Causes
Yaws is caused by T pallidum subsp pertenue, a slender spirochete, which is serologically and morphologically indistinguishable from the spirochete that causes syphilis (T pallidum). Like the other nonvenereal treponematoses, yaws is not found in urban centers, it is not sexually transmitted, and it is not congenitally acquired. Children serve as the primary reservoir for yaws, spreading the disease via skin-to-skin and skin-to-mucous membrane contact.
Atopic Dermatitis
Cutaneous Tuberculosis
Leishmaniasis
Leprosy
Psoriasis, Plaque
Rhinoscleroma
Sarcoidosis
Scabies
South American Blastomycosis
Syphilis
Tungiasis
Warts, Nongenital
Other Problems to be Considered
Differential diagnoses of skin lesions
Idiopathic keratoderma
Calluses
Arthropod bites
Vitamin deficiencies
Differential diagnoses of nasopharyngeal lesions
Rhinosporidiosis
Rhinoscleroma
Tuberculosis
South American blastomycosis
Mucocutaneous leishmaniasis
Nasopharyngeal carcinoma
Noma
Differential diagnoses of bone lesions
Venereal or endemic syphilis
Tuberculosis
Osteomyelitis
Sickle cell anemia
Lab Studies
- Microscopy: Diagnosis is made by clinical evaluation of lesions and confirmed by detection of treponemes on dark-field microscopy of serum obtained by squeezing the bases of the lesions.
- Serologic tests
- Serologic tests are identical to those for venereal syphilis, including rapid plasma reagent (RPR) test, Venereal Disease Research Laboratory (VDRL) test, fluorescent treponemal antibody absorption (FTA-ABS) test, T pallidum immobilization (TPI) test, and T pallidum hemagglutination assay (TPHA).
- RPR and VDRL tests are reactive 2-3 weeks after the onset of the primary lesion; they generally remain reactive throughout all stages.
- No serologic test can distinguish yaws from other nonvenereal treponematoses; therefore, diagnosis is ultimately based on correlation of the clinical findings, epidemiologic history, and positive serologic results that are suggestive of yaws.
Imaging Studies
- Radiologic studies are nonspecific but can include any of the following findings:
- Surface striations (periostitis)
- Cortical thickening with bowing (saber shin deformity)
- Spiculated periosteal reaction
- General osseous expansion
- Gummatous destruction
- Draining sinuses
- Epiphyseal separation
- Stellate frontal bone scans
Histologic Findings
Histologic findings in early yaws include acanthosis, papillomatosis, and spongiosis. Neutrophilic exocytosis with intraepidermal microabscess formation is the most characteristic finding. The dermis has a moderate-to-dense granulomatous infiltrate mainly composed of plasma cells and lymphocytes with few histiocytes, neutrophils, and eosinophils. Unlike syphilis, endothelial proliferation is absent or low.
Late yaws has histologic findings similar to that of tertiary syphilis, including an intense dermal infiltrate composed of epithelioid cells, giant cells, lymphocytes, and fibroblasts. Caseation necrosis can also be observed. Plasma cells and histiocytes, in contrast to early yaws, are scarce.
Silver stains (Steiner) can be used to identify numerous treponemes between keratinocytes in early yaws. They are seen in a bandlike pattern or in clusters in the epidermis. Unlike T pallidum, which is found in both the epidermis and the dermis, T pallidum subsp pertenue is almost entirely epidermotropic.
Electron microscopy of early lesions demonstrates scarce treponemes in clusters in the intercellular spaces of the epidermis among inflammatory cells, within the cytoplasm of macrophages, and in the dermis.
Medical Care
Treatment consists of appropriate antibiotic therapy. Penicillin remains the drug of choice for yaws. Tetracycline, erythromycin, or doxycycline should be considered for patients allergic to penicillin.
- Epidemiological treatment recommendations for yaws are as follows:
- If greater than 50% of children are seropositive (hyperendemic), treat the entire population.
- If 10-50% of children are seropositive (mesoendemic), treat active cases, contacts, and all children aged 15 years or younger.
- If less than 10 of children are seropositive (hypoendemic), treat active cases, household members, and other obvious contacts.
Penicillin remains the drug of choice for yaws. No resistant strains of T pallidum have been reported; however, in 1988, Backhouse and colleagues, while monitoring an outbreak of yaws in children on Karkar Island, Papua New Guinea, found evidence suggestive of resistant strains. Approximately 28% of children treated with penicillin developed clinical and/or serologic evidence of relapse or reinfection. This finding suggests that some strains of T pallidum subsp pertenue may have reduced susceptibility or increased tolerance to penicillin treatment. Nonetheless, according to the 1980 WHO Scientific Group on Treponemal Infections, penicillin is the recommended treatment.
Drug Category: Antibiotics
Empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens in the context of the clinical setting.
| Drug Name | Penicillin G benzathine (Bicillin LA) |
| Description | Interferes with synthesis of cell wall mucopeptides during active multiplication, which results in bactericidal activity. Given as single injection, which kills the treponemes within minutes, and lesions become noninfectious after 18-24 h. |
| Adult Dose | 1.2 million U single injection |
| Pediatric Dose | <10 years: 0.6 million U single injection >10 years: 1.2 million U single injection |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid can increase effectiveness by decreasing clearance; coadministration with tetracyclines can decrease effectiveness |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Caution in impaired renal function |
| Drug Name | Tetracycline (Sumycin) |
| Description | Treats gram-positive and gram-negative organisms as well as mycoplasmal, chlamydial, and rickettsial infections. Inhibits bacterial protein synthesis by binding with 30S and, possibly, 50S ribosomal subunits. May be used in adults and children > 8 y who are allergic to penicillin. |
| Adult Dose | 500 mg PO qid for 15 d |
| Pediatric Dose | <8 years: Not recommended >8 years: 250 mg PO qid for 15 d |
| Contraindications | Documented hypersensitivity; severe hepatic dysfunction |
| Interactions | Bioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; tetracyclines can increase hypoprothrombinemic effects of anticoagulants |
| Pregnancy | D - Unsafe in pregnancy
|
| Precautions | Photosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last one half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines |
| Drug Name | Erythromycin (E.E.S., E-Mycin, Ery-Tab) |
| Description | Inhibits bacterial growth, possibly by blocking dissociation of peptidyl tRNA from ribosomes causing RNA-dependent protein synthesis to arrest. Used for treatment of staphylococcal and streptococcal infections. In children, age, weight, and severity of infection determine proper dosage. When bid dosing is desired, half-total daily dose may be taken q12h. For more severe infections, double the dose. May be used in adults and children who are allergic to penicillin. |
| Adult Dose | 500 mg PO qid for 15 d |
| Pediatric Dose | 8 mg/kg PO divided qid for 15 d |
| Contraindications | Documented hypersensitivity; hepatic impairment |
| Interactions | Coadministration may increase toxicity of theophylline, digoxin, carbamazepine, and cyclosporine; may potentiate anticoagulant effects of warfarin; coadministration with lovastatin and simvastatin increases risk of rhabdomyolysis; decreases clearance of triazolam and midazolam; acute ergot toxicity possible with concurrent ergotamine or dihydroergotamine use |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | May aggravate the weakness of patients with myasthenia gravis; caution in liver disease; estolate formulation may cause cholestatic jaundice; GI adverse effects are common (give doses pc); discontinue use if nausea, vomiting, malaise, abdominal colic, or fever occur |
| Drug Name | Doxycycline (Bio-Tab, Doryx, Vibramycin) |
| Description | May be used in adults with a penicillin allergy. Inhibits protein synthesis and, thus, bacterial growth by binding to 30S and, possibly, 50S ribosomal subunits of susceptible bacteria. |
| Adult Dose | 100 mg PO bid for 15 d |
| Pediatric Dose | <8 years: Not recommended >8 years: 2-5 mg/kg/d PO divided qd/bid; not to exceed 200 mg/d |
| Contraindications | Documented hypersensitivity; severe hepatic dysfunction |
| Interactions | Bioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; tetracyclines can increase hypoprothrombinemic effects of anticoagulants; may decrease bactericidal effects of penicillin |
| Pregnancy | D - Unsafe in pregnancy
|
| Precautions | Photosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last one half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines |
Complications
- Unless treated, yaws can become a chronic, relapsing disease with skin, bone, and joint involvement. In 10% of cases, patients enter a late stage (tertiary stage) characterized by destructive cutaneous lesions and severely deforming bone and joint lesions. Neurologic and ophthalmologic involvement may also occur.
Prognosis
- Patients may develop relapses at intervals up to 5 years after infection.
- In 10% of patients, a late stage (tertiary stage) develops after 5-15 years. This stage is characterized by destructive skin lesions, bone lesions, and possible neurologic and ophthalmologic involvement (see Physical).
- Backhouse JL, Hudson BJ, Hamilton PA, Nesteroff SI. Failure of penicillin treatment of yaws on Karkar Island, Papua New Guinea. Am J Trop Med Hyg. Sep 1998;59(3):388-92. [Medline].
- Engelkens HJ, ten Kate FJ, Judanarso J, Vuzevski VD, van Lier JB, Godschalk JC, et al. The localisation of treponemes and characterisation of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis, or early infectious yaws. Genitourin Med. Apr 1993;69(2):102-7. [Medline].
- Farnsworth N, Rosen T. Endemic treponematosis: review and update. Clin Dermatol. May-Jun 2006;24(3):181-90. [Medline].
- Koff AB, Rosen T. Nonvenereal treponematoses: yaws, endemic syphilis, and pinta. J Am Acad Dermatol. Oct 1993;29(4):519-35; quiz 536-8. [Medline].
- Lupi O, Madkan V, Tyring SK. Tropical dermatology: bacterial tropical diseases. J Am Acad Dermatol. Apr 2006;54(4):559-78; quiz 578-80. [Medline].
- Rothschild BM, Heathcote GM. Characterization of the skeletal manifestations of the treponemal disease yaws as a population phenomenon. Clin Infect Dis. Aug 1993;17(2):198-203. [Medline].
- Sanchez MR. Endemic (Nonvenereal) Treponematoses. In: Freedberg IM, Eisen AZ, Wolff K, Austen F, Goldsmith LA, Katz S, eds. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York, NY: McGraw-Hill; 2003.
- Sehgal VN, Jain S, Bhattacharya SN, Thappa DM. Yaws control/eradication. Int J Dermatol. Jan 1994;33(1):16-20. [Medline].
Yaws excerpt Article Last Updated: Mar 23, 2007
|